Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/10739
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSanghera, S-
dc.contributor.authorFrew, E-
dc.contributor.authorRoberts, T-
dc.date.accessioned2015-05-05T11:19:11Z-
dc.date.available2015-04-17-
dc.date.available2015-05-05T11:19:11Z-
dc.date.issued2015-
dc.identifier.citationPharmacoeconomics, 33(5): 533-534, (May 2015)en_US
dc.identifier.issn1179-2027-
dc.identifier.urihttp://link.springer.com/article/10.1007%2Fs40273-015-0265-z-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/10739-
dc.languageENG-
dc.language.isoenen_US
dc.publisherSpringer International Publishingen_US
dc.titleAdapting the CHEERS statement for reporting cost-benefit analysis.en_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s40273-015-0265-z-
dc.relation.isPartOfPharmacoeconomics-
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.docx17.47 kBUnknownView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.